Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
326.00    -4.60 (-1.39%)
Bid:
325.80
Ask:
326.40
Spread: 0.60 (0.184%)
Market Cap: £1.73b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Response to Press Speculation

21 Feb 2022 07:00

RNS Number : 2057C
Hammerson PLC
21 February 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

21 February 2022

 

Response to press speculation

 

Hammerson plc (the "Company") notes recent press speculation.

Hammerson's strategy remains to realign the portfolio to focus on prime urban estates through disposals of non-core assets, to strengthen the balance sheet, and to re-cycle capital into its core portfolio and its development pipeline.

The Company confirms that it is in discussions with entities related to Redical Holdings AG on terms for a possible sale of its Victoria Gate and Victoria Quarter shopping centres.

There can be no certainty that a transaction will take place, but the Company confirms the pricing under discussion is £120m, which would represent a class 2 transaction. The Company will provide a further announcement if appropriate.

ENDS

This announcement has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

Company Secretariat responsible for RNS

Alice Darwall, Hammerson, General Counsel & Company Secretary

Tel: +44 207 887 4650 E: alice.darwall@hammerson.com

Investor Contact

Josh Warren, Hammerson, Director of Strategy & Investor Relations

Tel: +44 20 7887 1053 E: josh.warren@hammerson.com

 

Press Contacts

Natalie Gunson, Hammerson, Communications Director

Tel: +44 207 887 4672 E: Natalie.gunson@hammerson.com

FTI Consulting (for Hammerson)

John Waples

Tel: +44 20 3727 1000/ 07717 814 520 E: john.waples@fticonsulting.com

Dido LaurimoreTel: +44 20 3727 1305 / 07801 654 424 E: dido.laurimore@fticonsulting.com

Notes to Editors

Hammerson

Hammerson creates vibrant, continually evolving spaces, in and around thriving European cities, with a focus on prime urban estates and premium outlets. As at 30 June 2021, our portfolio of high-quality venues had a value of £5.5 billion and included 21 flagship destinations in thriving cities and investments in premium outlet villages through our partnership with Value Retail. Key venues include Bullring, Birmingham, Dundrum Town Centre, Dublin, and Les Terrasses du Port, Marseille, and investments in premium outlets at Bicester Village, Oxfordshire, La Vallée, Paris, and Las Rozas, Madrid.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCBKKBQFBKDKBB
Date   Source Headline
5th Jun 20268:00 amRNSPublication of Final Terms
2nd Jun 20267:00 amRNSSuccessful pricing of 5-year EUR350m bond
29th May 20263:45 pmRNSHolding(s) in Company
26th May 202610:00 amRNSResults of Dividend Reinvestment Plan
22nd May 20264:15 pmRNSDirector/PDMR Shareholding
19th May 20262:00 pmRNSDirector/PDMR Shareholding
15th May 202612:30 pmRNSDirector/PDMR Shareholding
14th May 20263:00 pmRNSDirector/PDMR Shareholding
30th Apr 20264:30 pmRNSTotal Voting Rights
30th Apr 202611:15 amRNSResult of AGM
30th Apr 20267:00 amRNSHammerson CFO to retire
29th Apr 20267:00 amRNSHolding(s) in Company
28th Apr 20263:00 pmRNSDirector/PDMR Shareholding
24th Apr 20261:30 pmRNSEMTN Programme: Publication of Base Prospectus
24th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSHolding(s) in Company
8th Apr 20264:00 pmRNSDirector/PDMR Shareholding
7th Apr 202612:45 pmRNSTotal Voting Rights and Capital
30th Mar 202610:00 amRNSDirector/PDMR Shareholding
26th Mar 202611:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Mar 20262:00 pmRNSDirector/PDMR Shareholding
17th Mar 202610:00 amRNSDirector/PDMR Shareholding
17th Mar 20269:00 amRNSDividend Currency Conversion Announcement
25th Feb 20267:01 amRNSDividend Declaration
25th Feb 20267:00 amRNSFinal Results
6th Feb 20267:00 amRNSDirectorate change
28th Jan 20269:00 amRNSNotice of Results
20th Jan 20263:30 pmRNSHolding(s) in Company
22nd Dec 202511:30 amRNSDirector/PDMR Shareholding
22nd Dec 20259:30 amRNSDirector/PDMR Shareholding
15th Dec 20253:00 pmRNSDirector/PDMR Shareholding
11th Dec 20252:15 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSDirectorate change
21st Nov 20257:00 amRNSAcquisition of The Oracle and Trading Update
13th Nov 20251:45 pmRNSDirector/PDMR Shareholding
31st Oct 20257:45 amRNSResults of Dividend Reinvestment Plan
28th Oct 20251:00 pmRNSDirector/PDMR Shareholding
24th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 202511:00 amRNSDirector/PDMR Shareholding
22nd Oct 20254:30 pmRNSDirector/PDMR Shareholding
21st Oct 202512:00 pmRNSDirector/PDMR Shareholding
16th Oct 20251:00 pmRNSPublication of Final Terms
9th Oct 20257:00 amRNSBond Pricing, Guidance & Operational Update
25th Sep 20254:30 pmRNSHolding(s) in Company
19th Sep 20253:30 pmRNSDirector/PDMR Shareholding
11th Sep 20254:45 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNSAppointment of Rob Wilkinson as CEO
4th Sep 20253:30 pmRNSPublication of Supplementary EMTN Prospectus
29th Aug 202512:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.